API reference
Ubrogepant
- CAS number
- 1374248-77-7
- Molecular formula
- C29H26F3N5O3
- Molecular weight
- 549.5 g/mol
About this molecule
Ubrogepant is an orally available, small molecule inhibitor of the calcitonin gene-related peptide (CGRP) receptor that blocks the action of CGRP, a potent vasodilator believed to play a role in migraine headaches. Ubrogepant is approved for treatment of acute migraine attacks. In clinical trials, urbrogepant was generally well tolerated with only rare instances of transient serum aminotransferase elevations during therapy and with no reported instances of clinically apparent liver injury.
Source: LiverTox, via PubChem.
Identifiers
- IUPAC name
- (3S)-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide
- InChIKey
- DDOOFTLHJSMHLN-ZQHRPCGSSA-N
- SMILES
- C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6
- PubChem CID
- 68748835
Also known as
Ubrogepant · Ubrelvy · Ubrogepant anhydrous · Ubrogepantum · Ubrelvy (TN) · Ubrogepant (Standard) · Ubrogepant (USAN/INN)
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.